Peptide Blood Tests: What Labs to Run and How to Monitor

A peptide blood test is a laboratory panel designed to measure biomarkers affected by peptide therapy, including IGF-1, glucose metabolism markers, hormone levels, and inflammatory indicators. Regular blood work helps you track how your body responds to peptides, catch potential side effects early, and optimize dosing. Without proper lab monitoring, you're essentially flying blind—you won't know if that GH secretagogue is actually raising your IGF-1 or if that GLP-1 analog is tanking your thyroid.

What Blood Tests Should You Run While Taking Peptides?

The specific blood tests you'll need depend entirely on which peptides you're using. There's no one-size-fits-all panel here. A guy running CJC-1295 and ipamorelin needs completely different labs than someone using semaglutide or BPC-157.

That said, most peptide protocols benefit from three testing phases: baseline (before you start), mid-cycle monitoring (usually 4-6 weeks in), and follow-up assessment (after completing or during extended use). You can't know if something's working—or causing problems—without comparing numbers over time.

Blood work also gives you leverage with your prescriber. If your IGF-1 hasn't budged after six weeks on a GH secretagogue, you've got data to justify adjusting the dose or switching peptides. Same goes for metabolic markers on GLP-1s or hormone levels on recovery peptides.

Cost matters too. Diagnostic testing can get expensive if you're ordering everything through traditional labs. Many people now use direct-to-consumer services or work with longevity clinics that bundle peptide-specific panels.

Baseline Labs: What to Test Before Starting Any Peptide

Before starting any peptide protocol, you should run a comprehensive baseline panel that includes: complete metabolic panel (CMP), lipid panel, complete blood count (CBC), thyroid function (TSH, Free T3, Free T4), fasting insulin and glucose, HbA1c, and high-sensitivity CRP.

Why? Because you need a reference point. If your fasting glucose is 105 mg/dL before starting a GH secretagogue and it jumps to 115 six weeks later, you know the peptide might be affecting insulin sensitivity. Without that baseline, you're just guessing.

The CMP catches kidney and liver function issues. Some peptides stress these organs, and if you've got pre-existing problems, you need to know before you start. Same logic applies to thyroid—GLP-1 peptides occasionally suppress thyroid function, so you want those numbers documented upfront.

Lipid panels establish your cardiovascular baseline. Many longevity-focused peptides impact cholesterol and triglycerides, sometimes positively, sometimes not. You won't know which direction things are moving without a starting point.

CBC is cheap insurance. It'll flag anemia, immune system weirdness, or platelet abnormalities that might contraindicate certain peptides. Most people skip this and regret it later when something odd shows up mid-protocol.

High-sensitivity CRP measures systemic inflammation. Recovery peptides like BPC-157 and TB-500 should theoretically lower this number. If yours is elevated at baseline, you've got a quantifiable target to track improvement against.

GH Secretagogue Monitoring: IGF-1, Fasting Glucose, HbA1c

If you're running growth hormone secretagogues—CJC-1295, ipamorelin, MK-677, tesamorelin—your primary monitoring focus is IGF-1 levels. That's the number that tells you whether the peptide is actually doing what it's supposed to do.

For GH secretagogue monitoring, test IGF-1, fasting glucose, fasting insulin, and HbA1c at baseline and every 4-6 weeks during use. IGF-1 should rise into the upper-normal or slightly supraphysiological range if dosing is effective. Most guys aim for 250-350 ng/mL depending on age and goals.

But here's the thing nobody talks about: GH secretagogues can mess with glucose metabolism. Some people develop insulin resistance, especially on higher doses or with MK-677. That's why you can't just check IGF-1 and call it good.

Fasting glucose should stay under 100 mg/dL ideally, though up to 110 might be acceptable short-term. If it creeps over that, you're potentially trading muscle gains for metabolic dysfunction. Not a great deal.

Fasting insulin is even more sensitive than glucose. You want this under 10 μIU/mL, ideally under 5. Rising insulin while glucose stays stable is an early warning sign that your body's compensating—it's pumping out more insulin to keep glucose in check. That compensation eventually fails.

HbA1c gives you a three-month average of blood sugar control. If fasting glucose looks fine but HbA1c is climbing, you're spiking at times you're not measuring. This is especially common with bedtime dosing of GH secretagogues.

Some people also monitor HOMA-IR, a calculated insulin resistance score. It's not a direct lab test—you calculate it from fasting glucose and insulin—but it's a solid way to track metabolic health over time. Rising HOMA-IR means you need to reassess dosing or add metformin or berberine.

GLP-1 Monitoring: Metabolic Panel, Lipids, Thyroid

GLP-1 receptor agonists—semaglutide, tirzepatide, retatrutide—have a completely different monitoring protocol. These aren't raising growth hormone; they're manipulating satiety hormones and insulin secretion. Different mechanism, different labs.

For GLP-1 peptide monitoring, test comprehensive metabolic panel (CMP), lipid panel, thyroid function (TSH, Free T3, Free T4), and fasting glucose every 6-8 weeks during active use.

The metabolic panel catches kidney stress. GLP-1s reduce appetite significantly, and if you're not drinking enough water, kidney function can take a hit. Creatinine and BUN should stay stable. If they're rising, you're likely dehydrated or pushing dosage too aggressively.

Lipids usually improve dramatically on GLP-1s. Triglycerides often drop 30-50%, LDL improves, HDL might rise slightly. But occasionally someone has a paradoxical response—LDL goes up instead of down. Without testing, you won't catch that until it's a problem.

Thyroid monitoring is non-negotiable. There's a small but real risk of thyroid suppression with GLP-1s, especially in people with existing thyroid antibodies. TSH climbing above 4.0 μIU/mL is a red flag. Free T3 dropping below mid-range suggests your thyroid's struggling to keep up.

Some prescribers also check gallbladder enzymes (ALT, AST, GGT) since rapid weight loss on GLP-1s can increase gallstone risk. If liver enzymes start climbing, you might need to slow your roll or add supportive supplements.

Fasting glucose should drop significantly—that's partly why people use these peptides. If it's not budging after 4-6 weeks, either your dose is too low or you've got severe insulin resistance that needs addressing with other interventions.

Testosterone Peptide Labs: LH, FSH, Total/Free T, Estradiol

If you're using peptides that impact the hormonal axis—gonadorelin, kisspeptin, or any GH secretagogue that might suppress natural production—you need a full hormone panel.

For testosterone-related peptide monitoring, test LH, FSH, total testosterone, free testosterone, estradiol (sensitive), and SHBG at baseline and every 6-8 weeks.

LH and FSH tell you whether your pituitary is still functioning normally. If you're using a GnRH analog like gonadorelin to stimulate natural testosterone, LH should rise. If it's not rising—or worse, if it's dropping—the peptide isn't working as intended.

Some GH secretagogues suppress the HPG axis, especially at higher doses or with prolonged use. You'll see LH and FSH drop while total testosterone drifts downward. That's your signal to either cycle off or add HCG to maintain testicular function.

Total testosterone alone doesn't tell the full story. You need free testosterone and SHBG to understand what's actually bioavailable. Some peptides raise SHBG, which binds up more testosterone and leaves you with less free hormone despite normal total levels.

Estradiol monitoring prevents you from crashing estrogen too low or letting it climb too high. A lot of guys using peptides for body composition also run AI compounds, and it's stupidly easy to tank estradiol and feel like garbage. Keep it between 20-40 pg/mL for most guys.

Sensitive estradiol assays matter here. Standard tests aren't accurate at male physiological levels. If your lab doesn't specify "sensitive" or "LC-MS/MS," the results might be worthless.

Recovery Peptide Monitoring: CRP, Inflammatory Markers

Recovery and healing peptides—BPC-157, TB-500, thymosin alpha-1—don't usually require extensive lab monitoring, but tracking inflammation can help you quantify benefits.

For recovery peptide monitoring, test high-sensitivity CRP, ESR (erythrocyte sedimentation rate), and fibrinogen at baseline and after 4-6 weeks of use.

High-sensitivity CRP is the gold standard for systemic inflammation. If you're using BPC-157 for gut healing or TB-500 for tendon recovery, you'd expect CRP to drop. If it's not dropping—or if it's rising—either the peptide isn't working or something else is driving inflammation.

Normal ranges for hs-CRP are under 3.0 mg/L, but optimal is under 1.0. Athletic populations and people with chronic injuries often sit between 1.5-3.0. Dropping from 2.5 to 0.8 after six weeks on a recovery peptide is a solid outcome.

ESR and fibrinogen are older inflammation markers, but they're still useful for tracking systemic inflammatory conditions. ESR should stay under 20 mm/hr for men, under 30 for women. Fibrinogen should sit between 200-400 mg/dL.

Some people also check IL-6 and TNF-alpha if they've got access to specialty labs. These cytokines drive chronic inflammation and should theoretically decrease with immune-modulating peptides like thymosin alpha-1. But these tests are expensive and not always necessary unless you're dealing with autoimmune issues.

How Often to Retest

Testing frequency depends on the peptide, your goals, and how your body responds. There's no magic formula, but here's a reasonable framework.

Retest labs every 4-6 weeks during initial peptide protocols, then every 8-12 weeks once dosing is stable and you've confirmed the peptide is well-tolerated.

The first 4-6 weeks are critical. That's when most side effects emerge and when you'll see the biggest changes in biomarkers. If IGF-1 hasn't budged by week six on a GH secretagogue, it's probably not going to. Same with glucose issues on GLP-1s—if you're going to develop insulin resistance or thyroid suppression, it usually shows up early.

Once you've dialed in dosing and confirmed everything's stable, you can stretch testing intervals to 8-12 weeks. Some people go longer, but that's risky. Hormone levels can shift, metabolic markers can drift, and catching problems early is way easier than fixing them later.

If you're cycling peptides—say, running a GH secretagogue for 12 weeks, then taking 4-6 weeks off—test at the end of the cycle and again after the break. This tells you how quickly your body returns to baseline and whether you're accumulating any negative effects.

People using peptides year-round should probably test quarterly at minimum. Annual testing isn't sufficient for anything that's actively manipulating hormones or metabolism.

Understanding Your Results: Normal Ranges vs Optimal Ranges

Here's where most people screw up: they see "normal" on the lab report and assume everything's fine. But normal ranges are population averages, not targets for performance or longevity optimization.

Normal lab ranges represent the middle 95% of the population, which includes sick, sedentary, and elderly people. Optimal ranges are narrower and target values associated with better health outcomes and performance.

Take testosterone. Normal range might be 264-916 ng/dL depending on the lab. But a 30-year-old guy sitting at 300 ng/dL is technically "normal" while feeling like absolute garbage. Optimal for most guys under 40 is 600-900 ng/dL, sometimes higher depending on goals.

Same deal with thyroid. Normal TSH range is often 0.5-4.5 μIU/mL, but optimal is probably 1.0-2.0. Free T3 should be in the upper third of the reference range, not just "within normal limits."

Fasting insulin is another one. Labs might list normal as under 25 μIU/mL, which is insane. Anything over 10 suggests insulin resistance. Under 5 is optimal for metabolic health.

IGF-1 reference ranges are age-adjusted, which is fine for clinical diagnosis but not necessarily ideal for someone using peptides for performance or anti-aging. A 45-year-old might have a "normal" IGF-1 of 120 ng/mL, but that's normal for someone experiencing age-related GH decline. Raising it to 250-300 might be more aligned with health optimization.

This isn't medical advice—talk to your prescriber about target ranges. But if you're optimizing with peptides, you're probably not content sitting at the bottom of "normal."

Where to Get Peptide-Related Lab Work

You've got several options for getting blood work done, and cost varies wildly depending on which route you take.

For peptide-related lab work, you can order tests through direct-to-consumer services like Ulta Lab Tests, LabCorp OnDemand, or Quest Direct, use a longevity-focused telemedicine clinic, or ask your primary care physician for a requisition.

Direct-to-consumer labs are usually the cheapest option. You order online, pay upfront, get a requisition, and go to a local draw site. No doctor visit required. An IGF-1 test might run $50-80, a full hormone panel $150-250. Way cheaper than going through insurance in most cases.

Longevity clinics and telemedicine peptide prescribers often bundle lab monitoring into their protocols. You'll pay more per test, but it's convenient and they'll interpret results in the context of your specific protocol. Worth considering if you're not confident reading labs yourself.

Traditional primary care is hit-or-miss. Some doctors will order whatever you ask for. Others won't touch peptide monitoring with a ten-foot pole. If your doc is cool and your insurance covers it, great. But most people end up paying out-of-pocket either way because insurance doesn't consider "peptide optimization" medically necessary.

A few companies now offer at-home finger-stick tests for basic markers. These can work for tracking trends, but venous draws are more accurate for hormone testing. Finger-stick testosterone, for example, can vary by 20-30% compared to venous samples.

Whatever route you choose, make sure you're using the same lab for follow-up testing. Different labs use different assays, and reference ranges don't always match. Comparing an IGF-1 result from Quest to one from LabCorp six weeks later introduces unnecessary variables.

FAQ

Do you need blood work before starting peptides?

Yes, you absolutely should. Baseline labs establish your starting point and catch pre-existing conditions that might contraindicate certain peptides. Without baseline data, you can't tell whether changes in markers are due to the peptide or something else. At minimum, get a CMP, CBC, lipid panel, and any hormone markers relevant to your chosen peptide before you start.

What blood tests check IGF-1 levels for peptide monitoring?

A standard IGF-1 test (also called insulin-like growth factor 1 or somatomedin C) measures circulating IGF-1 levels. Some labs also offer IGF-1 Z-score, which adjusts for age. You want serum IGF-1, not IGF-1 LR3 (that's a different peptide entirely). Most direct-to-consumer labs offer this test for $50-80 without a doctor's order.

How often should you test blood work while on peptides?

Test every 4-6 weeks during the first 2-3 months, then every 8-12 weeks once dosing is stable. If you're cycling on and off, test at the end of each cycle and after breaks. More frequent testing makes sense if you're adjusting doses, stacking multiple peptides, or experiencing side effects. Less frequent testing is fine once you've confirmed stability and tolerability.

Can peptides affect liver enzymes on blood tests?

Some peptides can elevate liver enzymes (ALT, AST, GGT), particularly GLP-1 receptor agonists during rapid weight loss or in people with existing fatty liver disease. GH secretagogues occasionally raise enzymes at very high doses. If your liver enzymes climb above 1.5x the upper limit of normal, you should reduce dosage or stop the peptide and retest in 4-6 weeks. Moderate elevations (up to 1.5x) might be acceptable with close monitoring.

Do GLP-1 peptides require thyroid monitoring?

Yes. GLP-1 receptor agonists can suppress thyroid function in some people, and there's a black-box warning about medullary thyroid carcinoma risk (though actual human risk appears very low). Test TSH, Free T3, and Free T4 at baseline and every 6-8 weeks during use. If TSH climbs above 4.0 μIU/mL or Free T3 drops below mid-range, discuss thyroid support or alternative peptides with your prescriber.

What's a normal IGF-1 level on peptide therapy?

It depends on your age and goals. Reference ranges are age-adjusted, but many people using GH secretagogues aim for IGF-1 levels in the 250-350 ng/mL range regardless of age. Some push higher, into the 350-450 range, though this increases risk of side effects. Going above 450 ng/mL is generally not recommended outside of clinical growth hormone deficiency treatment. Work with your prescriber to set individual targets based on response and side effect profile.

Should you test fasting or non-fasting for peptide blood work?

Fasting is required for glucose, insulin, and lipid panels—typically 8-12 hours with only water allowed. Hormone tests (testosterone, IGF-1, thyroid) don't require fasting but should be done at a consistent time of day since many hormones fluctuate throughout the day. Morning draws (7-9 AM) are standard for testosterone. IGF-1 is more stable and can be tested anytime, but consistency matters for tracking trends.

Can you use at-home blood tests for peptide monitoring?

At-home finger-stick tests work for tracking general trends but aren't as accurate as venous draws for hormone testing. Companies like InsideTracker and Everlywell offer decent metabolic panels, but hormone assays (especially testosterone and estradiol) can vary significantly from venous samples. If you're making dosing decisions based on lab results, stick with venous draws from a certified lab. At-home tests are fine for between-cycle spot checks or rough trend monitoring.

What labs should you run if stacking multiple peptides?

Run the complete union of all relevant markers for each peptide in your stack. If you're running a GH secretagogue + GLP-1 + recovery peptide, you'd need: IGF-1, fasting glucose/insulin, HbA1c (for GH secretagogue), CMP, lipids, thyroid panel (for GLP-1), and hs-CRP (for recovery peptide). Yes, it gets expensive. That's why many people test the most important markers every 4-6 weeks and run a comprehensive panel every 12 weeks.

Do testosterone peptides suppress natural production?

It depends on the peptide. GnRH analogs like gonadorelin and kisspeptin are designed to stimulate natural production and shouldn't suppress LH/FSH. However, some GH secretagogues (especially MK-677 and high-dose CJC/ipamorelin) can suppress the HPG axis and lower LH, FSH, and testosterone over time. Test LH, FSH, total testosterone, and free testosterone every 6-8 weeks. If LH drops below 2.0 IU/L or testosterone declines more than 100 ng/dL from baseline, consider cycling off or adding HCG.

What's the best lab test for insulin resistance on peptides?

Fasting insulin is more sensitive than fasting glucose for detecting early insulin resistance. Pair it with fasting glucose and calculate HOMA-IR: (fasting insulin × fasting glucose) / 405. HOMA-IR under 1.0 is optimal, 1.0-2.0 is acceptable, above 2.0 suggests insulin resistance. HbA1c adds long-term context. If HOMA-IR is rising or HbA1c creeps above 5.3%, you might need to adjust peptide dosing, timing, or add insulin sensitizers like metformin or berberine.

How long after stopping a peptide should you retest labs?

Wait 4-6 weeks after stopping to assess how quickly markers return to baseline. Short-acting peptides (most research peptides) clear quickly, but downstream effects on hormones and metabolism can persist for weeks. IGF-1 typically drops back toward baseline within 2-4 weeks after stopping GH secretagogues. Thyroid function usually recovers within 6-8 weeks after stopping GLP-1s if suppression occurred. Testing too early might catch transitional values that don't reflect your true baseline.

Can blood tests tell if your peptide is fake or underdosed?

Yes, indirectly. If you're running a properly dosed GH secretagogue and IGF-1 doesn't rise after 4-6 weeks, either the peptide is bunk, underdosed, or degraded from poor storage. If a GLP-1 isn't dropping your fasting glucose or if thyroid markers aren't shifting at all, same issue. Blood work won't tell you the exact purity or concentration, but it'll tell you whether the peptide is having the expected physiological effects. If numbers don't move and dosing/timing are correct, source quality is the likely culprit.